Napredno

 
  Išči
    Enostavno iskanje


Rezultati

4 rezultati
1 - 4 / 4
Na začetekNa prejšnjo stran1Na naslednjo stranNa konec
1. Pharmacogenetic markers of adverse events of dopaminergic treatment in Parkinson's disease
Sara Redenšek, 2019, doktorsko delo/naloga

Ključne besede: Parkinson's disease, pharmacogenetics, dopaminergic treatment, adverse events, genetic polymorphisms, personalized medicine, clinical-pharmacogenetic models
Celotno besedilo (datoteka, 11,02 MB)

2. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, izvirni znanstveni članek

Ključne besede: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events
Celotno besedilo (datoteka, 411,70 KB) Gradivo ima več datotek! Več...

3. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease
Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, izvirni znanstveni članek

Ključne besede: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events
Celotno besedilo (datoteka, 673,75 KB) Gradivo ima več datotek! Več...

4. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events
Sara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, izvirni znanstveni članek

Ključne besede: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism
Celotno besedilo (datoteka, 279,78 KB) Gradivo ima več datotek! Več...
Iskanje izvedeno v 0.02 sek.
Na vrh